| 101 |
16507366 | Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. | 2006 Mar 3 |
1 |
| 102 |
16979156 | Selection of new chemical entities with decreased potential for adverse drug reactions. | 2006 Nov 7 |
1 |
| 103 |
15917227 | Nrf2 Possesses a redox-insensitive nuclear export signal overlapping with the leucine zipper motif. | 2005 Aug 5 |
1 |
| 104 |
15917255 | Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells. | 2005 Jul 22 |
1 |
| 105 |
16006525 | Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. | 2005 Jul 19 |
3 |
| 106 |
16030151 | Avicinylation (thioesterification): a protein modification that can regulate the response to oxidative and nitrosative stress. | 2005 Jul 19 |
1 |
| 107 |
16194107 | Screening method for the discovery of potential cancer chemoprevention agents based on mass spectrometric detection of alkylated Keap1. | 2005 Oct 1 |
1 |
| 108 |
15282410 | Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1. | 2004 Nov |
1 |
| 109 |
14585973 | Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. | 2003 Nov |
4 |
| 110 |
11948402 | Site-directed mutagenesis of cysteine to serine in the DNA binding region of Nrf2 decreases its capacity to upregulate antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene. | 2002 Mar 28 |
4 |